Navidea Biopharma (NYSE: NAVB) reported Q1 EPS of ($0.24), versus ($0.83) reported last year. Revenue for the quarter came in at $136 thousand, versus $275.65 thousand reported last year.

For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.